Reactions Weekly

, Volume 1153, Issue 1, pp 2–2 | Cite as

Novartis advises of updated prescribing information for Exjade

News item
  • 12 Downloads

Keywords

Neutropenia Vasculitis Urticaria Serum Creatinine Level Angioedema 

REFERENCE

  1. 1.
    Novartis.Important information about Exjade (Rm) (deferasirox) tablets for oral suspension. Internet Document: [4 pages], 14 May 2007. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations